Betrixaban Patent Expiration
Betrixaban is Used for preventing blood clots and thrombosis. It was first introduced by Portola Pharmaceuticals Inc
Betrixaban Patents
Given below is the list of patents protecting Betrixaban, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Bevyxxa | US8404724 | Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor | Mar 29, 2031 | Portola Pharms Inc |
Bevyxxa | US8987463 | Methods of synthesizing factor Xa inhibitors | Dec 28, 2030 | Portola Pharms Inc |
Bevyxxa | US8557852 | Methods of using crystalline forms of a salt of a factor Xa inhibitor | Sep 08, 2028 | Portola Pharms Inc |
Bevyxxa | US7598276 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | Nov 08, 2026 | Portola Pharms Inc |
Bevyxxa | US9555023 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | Nov 07, 2026 | Portola Pharms Inc |
Bevyxxa | US6376515 | Benzamides and related inhibitors of factor Xa |
Sep 15, 2020
(Expired) | Portola Pharms Inc |
Bevyxxa | US6835739 | Benzamides and related inhibitors of factor Xa |
Sep 15, 2020
(Expired) | Portola Pharms Inc |
Bevyxxa | US8518977 | Benzamides and related inhibitors of factor XA |
Sep 15, 2020
(Expired) | Portola Pharms Inc |
Bevyxxa | US8691847 | Benzamides and related inhibitors of factor Xa |
Sep 15, 2020
(Expired) | Portola Pharms Inc |
Bevyxxa | US9629831 | Benzamides and related inhibitors of factor XA |
Sep 15, 2020
(Expired) | Portola Pharms Inc |
Betrixaban's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List